Enzymatic DNA Templates for RNA Manufacturing Market
完整報告名稱與涵蓋範圍
Enzymatic DNA Templates for RNA Manufacturing Market Size, Share & Trends Analysis Report, By Template Type (Linear Enzymatically Amplified DNA (Doggybone and Related Formats), Synthetic and Cell-Free Amplified Linear DNA, PCR-Amplified Templates, Plasmid DNA Templates (Reference Segment)), By Grade (Research Grade, GMP Grade), By Application (mRNA and Self-Amplifying RNA Manufacturing, Viral Vector and Gene Therapy Production, DNA Vaccines and Other Applications), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The enzymatic DNA templates for RNA manufacturing market covers linear DNA produced by cell-free enzymatic amplification, synthetic and cell-free assembled linear DNA and PCR-amplified templates used as starting material for in vitro transcription, viral vector production and DNA vaccines, with plasmid DNA templates analysed as the incumbent reference. Plasmid manufacturing itself is covered in adjacent studies and excluded from revenue except as a comparison benchmark.
Enzymatic templates are gaining adoption because they avoid bacterial fermentation, antibiotic resistance genes and bacterial sequence contaminants, shorten template production from weeks to days and scale in cell-free reactions that can be run in standard manufacturing suites. These attributes matter for personalised cancer vaccines that need a new template per patient, for rapid pandemic response and for regulators increasingly attentive to residual DNA impurities. Producers are expanding GMP capacity, securing regulatory acceptance through clinical programs that used enzymatic templates and licensing technology to CDMOs and originators, while cost per milligram and long-sequence fidelity remain the main comparison points against plasmid.
The United Kingdom and United States host the leading technology owners, with adoption spreading through European and North American CDMOs and interest rising in Japan and China. Competition involves cell-free DNA technology companies, gene synthesis firms and plasmid manufacturers adding enzymatic options.
The InsightAce study includes revenue forecasts in US$ for all template type, grade, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Enzymatic DNA Templates for RNA Manufacturing Market Snapshot
Chapter 4. Global Enzymatic DNA Templates for RNA Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Template Type Estimates & Trend Analysis
5.1. Template Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Template Type:
5.2.1. Linear Enzymatically Amplified DNA (Doggybone and Related Formats)
5.2.2. Synthetic and Cell-Free Amplified Linear DNA
5.2.3. PCR-Amplified Templates
5.2.4. Plasmid DNA Templates (Reference Segment)
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA and Self-Amplifying RNA Manufacturing
7.2.2. Viral Vector and Gene Therapy Production
7.2.3. DNA Vaccines and Other Applications
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. RNA and Gene Therapy Developers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. Enzymatic DNA Templates for RNA Manufacturing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Touchlight Genetics Ltd.
11.2. 4basebio PLC
11.3. Telesis Bio Inc.
11.4. Aldevron (Danaher)
11.5. GenScript Biotech Corporation
11.6. Charles River Laboratories International, Inc.
11.7. VGXI, Inc.
11.8. Thermo Fisher Scientific Inc.
11.9. Twist Bioscience Corporation
11.10. Elegen Corporation
11.11. Ansa Biotechnologies, Inc.
11.12. Kaneka Eurogentec S.A.
11.13. Merck KGaA (MilliporeSigma)
11.14. PlasmidFactory GmbH
11.15. Andelyn Biosciences, Inc.
圖表清單 List of Tables & Figures
Table 1. Global Enzymatic DNA Templates for RNA Manufacturing Market Revenue Forecast by Template Type, 2026-2035 (US$ Mn)
Figure 1. Global Enzymatic DNA Templates for RNA Manufacturing Market Segmentation and Scope Overview
Table 2. Global Enzymatic DNA Templates for RNA Manufacturing Market Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global Enzymatic DNA Templates for RNA Manufacturing Market Share by Template Type, 2026 & 2035
Table 3. Global Enzymatic DNA Templates for RNA Manufacturing Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Plasmid Versus Enzymatic Template Production: Timeline, Impurity and Cost Comparison
Table 4. Global Enzymatic DNA Templates for RNA Manufacturing Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Enzymatic DNA Adoption Across mRNA, Viral Vector and Personalised Vaccine Programs, 2026-2035
Table 5. Global Enzymatic DNA Templates for RNA Manufacturing Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Enzymatic DNA Templates for RNA Manufacturing Growth Opportunity Analysis
Table 6. North America Enzymatic DNA Templates for RNA Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Enzymatic DNA Templates for RNA Manufacturing Market Participants
Table 7. Europe Enzymatic DNA Templates for RNA Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Enzymatic DNA Templates for RNA Manufacturing Market
Table 8. Asia Pacific Enzymatic DNA Templates for RNA Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Regulatory Acceptance Milestones for Cell-Free DNA Templates
Table 9. Strategic Developments of Leading Enzymatic DNA Templates for RNA Manufacturing Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們